Differential expression of TP53 associated genes in Fanconi anemia cells after mitomycin C and hydroxyurea treatment

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 656, Issue 1-2, 2008, Pages 1-7

  Martinez, Angélica ^a,b   Hinz, John M ^c   Gómez, Laura ^a   Molina, Bertha ^a   Acuña, Hilda ^a   Jones, Irene M ^d   Frias, Sara ^a   Coleman, Matthew A ^d  

^a INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c WASHINGTON STATE UNIVERSITY   (United States)

^d Materials   (United States)

Author keywords

Apoptosis; Cell cycle arrest; Fanconi anemia; Gene expression; Hydroxyurea; Mitomycin C; TP53

Indexed keywords

HYDROXYUREA; MITOMYCIN C; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL ASSAY; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL KILLING; CELLULAR STRESS RESPONSE; CHROMOSOME ABERRATION; CHROMOSOME DAMAGE; CONTROLLED STUDY; DNA CROSS LINKING; DNA DAMAGE; DNA REPAIR; DOUBLE STRANDED DNA BREAK; FANCONI ANEMIA; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION;

CELL LINE; CHROMOSOME ABERRATIONS; CROSS-LINKING REAGENTS; DNA DAMAGE; FANCONI ANEMIA; GENE EXPRESSION REGULATION; GENES, P53; HUMANS; HYDROXYUREA; MITOMYCIN; NUCLEIC ACID SYNTHESIS INHIBITORS;

EID: 53249095473     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2008.06.012     Document Type: Article

References (44)

1. Mathew C.G. Fanconi anemia genes and susceptibility to cancer. Oncogene 25 (2006) 5875-5884
2. Gurtan A., and D'Andrea A. Dedicated to the core: understanding the Fanconi anemia complex. DNA Repair (Amst.) 5 (2006) 1119-1125
3. Cohen-Hagunauer 0., Peault B., Bauche C., Daniel M.T., Casa I., Levy V., Dausset J., Boiron M., Auclair Ch., Gluckman E., and Marty M. In vivo repopulation ability of genetically corrected bone marrow cells from Fanconi anemia patients. PNAS 103 (2006) 2340-2345
4. Sasaki M.S., and Tonomura A. A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents. Cancer Res. 8 (1973) 1829-1836
5. Medhurts A.L., Laghmani H., Steltenpool J., Ferrer M., Fontaine C., de Groot J., Rooimans M., Scheper R.J., Meetei A.R., Wang W., Joenje H., and de Winter J.P. Evidence for subcomplexes in the Fanconi anemia pathway. Blood 108 (2006) 2072-2080
6. Reid S., Schindler D., Hanenberg H., Barker K., Hanks S., Kalb R., Neveling K., Kelly P., Seal S., Freund M., Wurm M., Batish S.D., Lanch F.P., Yetgin S., Neitzel H., Aniffin H., Tischkowitz M., Mathew C.G., Averbach A.D., and Rahman N. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predisponse to childhood cancer. Nat. Genet. 2 (2007) 162-164
7. Kennedy R., and D'Andrea A.D. The Fanconi anemia/BRCA pathway: new faces in the crowd. Gene Dev. 19 (2005) 2925-2940
8. Meetei A., de Winter J., Medhurst A., Wallisch M., Waisfisz Q., Vrugt H., Oostra A., Yan Ch., Bishop C., Hoatlin M., Joenje H., and Wang W. A novel ubiquitin ligase is Fanconi anemia. Nat. Genet. 35 (2003) 165-170
9. Garcia-Higuera I., Kuang Y., Naf D., Wasik J., and D'Andrea A.D. Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex. Mol. Cell Biol. 19 (1999) 4866-4873
10. Howlet N.G., Taniguchi T., Durkin S.G., D'Andrea A.D., and Glover T.W. The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability. Hum. Mol. Genet. 14 (2005) 693-701
11. Hinz J.M., Nham P.B., Salazar E.P., and Thompson L.H. The Fanconi anemia pathway limits the severity of mutagenesis. DNA repair (Amst.) 5 (2006) 875-884
12. Rahman N., Seal S.H., Thompson D., Kelly P., Renwick A., Elliott A., Reid S., Spanova K., Barfoot R., Chagtai T., Jayatilake H., McGuffog L., Hanks S., Evans D.G., Eccles D., The Breast Cancer Susceptibility Collaboration (UK), D. Easton, and M. Stratton. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat. Genet. 39 (2007) 165-167
13. Taniguchi T., Garcia-Higuera I., Andreassen P.R., Gregory R.C., Grompe M., and D'Andrea A.D. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 100 (2002) 2414-2420
14. Smogorzewska A., Matsuoka S., Vinciguerra P., McDonald E.R., Hurov K.E., Luo J., Ballif B.A., Gygi S.P., Hofmann K., D'Andrea A.D., and Elledge S.J. Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell 129 (2007) 289-301
15. Koc A., Wheeler L.J., Mathews C.K., and Merrill G.F. Hydroxyurea arrests DNA replication by mechanism that preserves basal dNTP pools. J. Biol. Chem. 279 (2004) 223-230
16. Mattia M., Gottifredi V., Mckinney K., and Prives C. P53-Dependent p21 mRNA elongation is impaired when DNA replication is stalled. Mol. Cell Biol. 27 (2007) 1309-1320
17. Ho C.C., Siu W.Y., Lau A., Chan W.M., Arooz T., and Poon R. Stalled replication induces p53 accumulation through distinct mechanisms from DNA damage checkpoint pathways. Cancer Res. 66 (2006) 2233-2241
18. Frias S., Gomez L., Molina B., Rojas E., Ostrosky-Wegman P., and Carnevale A. Effect of hydroxyurea and normal plasma on DNA synthesis in lymphocytes from Fanconi anemia patients. Mutat. Res. 357 (1996) 115-121
19. Yu J., and Zhang L. The transcriptional targets of p53 in apoptosis control. Biochem. Biophys. Res. Commun. 331 (2005) 851-858 Review
20. +/-) accelerates epithelial tumor formation in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Cancer Res. 65 (2005) 85-91
21. Lui T.X., Howlett N.G., Deng M., Langenau D.M., Hsu K., Rhodes J., Kanki J.P., D'Andrea A.D., and Look A.T. Knockdown of Zebra fish Fancd2 causes developmental abnormalities via p53-dependent apoptosis. Dev. Cell 5 (2003) 903-914
22. -ΔΔCT method. Methods 25 (2001) 402-408
23. Esmer C., Sanchez S., Ramos S., Molina B., Frias S., and Carnevale A. DEB test for Fanconi anemia detection in patients with atypical phenotypes. Am. J. Med. Genet. A 124 (2004) 35-39
24. B. Molina, L. Gómez, A. Hernández-Jardines, R. Ortiz, A.Carnevale, M. Altamirano-Lozano, S. Frias, Hydroxyurea produces chromosome damage in Fanconi anemia cells in A, B, C, D1 and E complementations groups (submitted for publication).
25. Waisfisz Q., Miyazato A., de Winter J.P., Lui J.M., and Joenje H. Analysis of baseline and cisplatin-inducible gene expression in Fanconi anemia cells using oligonucleotide-based microarrays. BMC Blood Disord. 2 (2002) 1-9
26. Kannan K., Amariglio N., Rechavi G., Jakob-Hirsch J., Kela I., Kaminski N., Getz G., Domanny E., and Givol D. DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene 20 (2001) 225-234
27. Helton E.S., and Chen X. P53 modulation of the DNA damage response. J. Cell Biochem. 100 (2007) 883-896 Review
28. Harms K., Nozell S., and Chen X. The common and distinct target genes of the p53 family trasncription factors. Cell. Mol. Life Sci. 61 (2004) 822-842 Review
29. Freie B., Li X., Ciccone S.L., Nawa K., Cooper S., Vogelweid C., Schantz L., Heneline L.S., Orazi A., Broxmeyer H., Lee S., and Clapp D.W. Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis. Blood 102 (2003) 4146-4152
30. Hinz J.M., Nham P.B., Urbin S.S., Jones I.M., and Thompson L.H. Disparate contributions of the Fanconi anemia pathway and homologous recombination in preventing spontaneous mutagenesis. Nucleic Acids Res. 35 (2007) 3733-3740
31. Joenje H., and Patel K.J. The emerging genetic and molecular basis of Fanconi anaemia. Nat. Rev. Genet. 6 (2001) 446-457 Review
32. Lima P.D., Cerqueira dos Santos P., Salim A., De Olivera M., and Rodriguez R. Evaluation of the mutagenic activity of hydroxyurea on the G1-S-G2 phases of the cell cycle: an in vitro study. Genet. Mol. Res. 2 (2003) 328-333
33. Zhao R., Gish K., Murphy M., Yin Y., Notterman D., Hoffman W.H., Tom E., Mack D., and Levine A.J. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev. 14 (2000) 981-993
34. R. Rahman-Roblick, U.J. Roblick, U. Hellman, P. Conrotto, T. Lui, S. Becker, D. Hirschberg, Jôrnvall, G. Auer, KG. Wiman p53 targets identified by protein expression profiling, Proc. Natl. Acad. Sci. 104 (2007) 5401-5406.
35. Niedernhofer L.J. The Fanconi anemia signalosome anchor. Mol. Cell 25 (2007) 487-490
36. -/- cells is couple with S phase checkpoint defects. Cell Cycle 4 (2005) 704-709
37. Kruyt F.A., Dijkmans L.M., van de Berg T.K., and Joenje H. Fanconi anemia genes act to suppress a cross-linker-inducible p53-independet apoptosis pathway in lymphoblastoid cell lines. Blood 87 (1996) 938-948
38. Nicolls C.D., Shields M.A., Lee P.W., Robbins S.M., and Beattie T.L. UV-dependent alternative splicing uncouples p53 activity and PIG3 gene function through rapid proteolytic degradation. J. Biol. Chem. 279 (2004) 24171-24178
39. Coleman M.A., Yin E., Peterson L.E., Nelson D., Sorensen K., Tucker J.D., and Wyrobek A.J. Low response irradiation alters the transcript profiles of human lymphoblastoid cells including genes associated with cytogenetic radioadaptative response. Radiat. Res. 164 (2005) 369-382
40. Meetie A.R., Sechi S., wallisch M., Yang D., Young M.K., Joenje H., Hoatlin M.E., and Wang W. A multiplotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol. Cell Biol. 23 (2003) 3417-3426
41. Davalos A.R., and Campisi J. Bloom syndrome cells undergo p53-dependent apoptosis and delayed assembly of BRCA1 and NBS1 repair complex at stalled replication forks. J. Cell Biol. 162 (2003) 1197-1209
42. Niedernhofer L.J., Odijk H., Budzowska M., van Drunen E., Maas A., Theil A.F., de wit Jaspers N.G., Beverloo H.B., Hoeijmaker J.H., and Kanaar R. The structure specific endonuclease Ercc1-Xpf required to resolve DNA interstrand cross-link induced double-strand breaks. Mol. Cell Biol. 24 (2004) 5776-5787
43. Futaki M., Igarashi T., Watanabes S., Kajigaya S., Tatsuguchi A., Wang J., and Lui J.M. The FACNG Fanconi anemia protein interacts with CYP2EY: possible role in protection against oxidative DNA damage. Carcinogenesis 23 (2002) 67-72
44. Mukhopadhyay S.S., Leung K.S., Hicks M.J., Hasting P.J., Youssoufian H., and Plon S.E. Detective mitochondrial peroxiredoxin-3 results in sensitivity to oxidative stress in Fanconi anemia. J. Cell Biol. 175 (2006) 225-235